JAMPSOYL SUGAR FREE 78 %
MINERAL OIL : 78 % · DIN 02359154 · JAMP PHARMA CORPORATION
Health Canada status: APPROVED
What is JAMPSOYL SUGAR FREE?
JAMPSOYL SUGAR FREE 78 % contains MINERAL OIL : 78 %. It is listed in the Health Canada Drug Product Database under DIN 02359154, held by JAMP PHARMA CORPORATION, supplied as GEL for ORAL administration. Health Canada currently lists it as approved, status dated 03-Nov-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02359154 |
|---|---|
| Brand name | JAMPSOYL SUGAR FREE |
| Generic / active ingredient | MINERAL OIL : 78 % |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 78 % |
| Dosage form | GEL |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AA01 LIQUID PARAFFIN |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 03-Nov-2010 |
What can be used instead?
Other Canadian products sharing ATC code A06AA01 LIQUID PARAFFIN. 6 of 32 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLEET ENEMA MINERAL OIL | 100 % | ENEMA | C B FLEET COMPANY INC | MARKETED | DIN 00107875 |
| HUILE MINERALE LOURDE LIQ 100% USP | 100 % | LIQUID | LABORATOIRE ATLAS INC | MARKETED | DIN 00704172 |
| LANSOYL GEL 78% | 78 % | GEL | AURIUM PHARMA INC. | MARKETED | DIN 00608734 |
| MINERAL OIL | 100 % | LIQUID | TEVA CANADA LIMITED | MARKETED | DIN 00485802 |
| MINERAL OIL (HEAVY) | 100 % | LIQUID | RW CONSUMER PRODUCTS LTD | MARKETED | DIN 01935348 |
| MINERAL OIL USP | 99.9 % | SOLUTION | VI-JON, LLC | MARKETED | DIN 02381834 |
| CANADIAN NATIONAL PHARMA GROUP INC MINERAL OIL HEAVY USP | 100 % | LIQUID | CANADIAN NATIONAL PHARMA GROUP INC | APPROVED | DIN 02439506 |
| GELEE LAXATIVE A LA FRAMBOISE | 78 % | GEL | PHARMALAB INC. | CANCELLED PRE MARKET | DIN 02312387 |
| HEAVY MINERAL OIL | LIQUID | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00093947 | |
| HEAVY MINERAL OIL | LIQUID | BIONATAL DRUG CO | CANCELLED POST MARKET | DIN 00366676 |
Who else supplies LIQUID PARAFFIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LIQUID PARAFFIN appears in 11 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.